References
Adami, H.O., Zack, M., Kressner, U., Persson, I., Berglund, A., Naessen, T., et al. (1990). Hip fractures in women with breast cancer. American Journal of Epidemiology, 132(5), 877-883.
Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
Ainsworth, B.E., Sternfeld, B., Richardson, M.T., & Jackson, K. (2000). Evaluation of the Kaiser Physical Activity Survey in women. Medicine and Science in Sports and Exercise, 32(7), 1327-1338.
American Cancer Society. (2007). Cancer facts and figures 2007. Atlanta, GA: Author.
American Geriatric Society. (2001). The prevention of falls in older persons. Journal of the American Geriatric Society, 49(5), 664-672.
Arlot, M.E., Sornay-Rendu, E., Garnero, P., Vey-Marty, B., & Delmas, P.D. (1997). Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: The OFELY cohort. Journal of Bone and Mineral Research, 12(4), 683-690.
Beck, B.R., & Snow, C.M. (2003). Bone health across the lifespan-Exercising our options. Exercise and Sports Science Review, 31(3), 117-122.
Binkley, N., Bilezikian, J.P., Kendler, D.L., Leib, E.S., Lewiecki, E.M., & Petak, S.M. (2007). Summary of the International Society for Clinical Densitometry 2005 Position Development Conference. Journal of Bone and Mineral Research, 22(5), 643-645.
Blake, A., Morgan, K., Bendall, M., Dallosso, H., Ebrahim, S., & Arie, T. (1988). Falls by elderly people at home: Prevalence and associated factors. Age and Ageing, 17(6), 365-372.
Boehmke, M.M., & Dickerson, S.S. (2005). Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nursing, 28(5), 382-389.
Bruning, P., Pit, M., Jong-Bakker, M.D., Ende, A.V.D., Hart, A., & Enk, A.V. (1990). Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. British Journal of Cancer, 61(2), 308-310.
Campbell, A., Borrie, M., & Spears, G. (1989). Risk factors for falls in a community-based prospective study of people 70 years and older. Journal of Gerontology, 44(4), 112-117.
Cauley, J.A., Petrini, A.M., LaPorte, R.E., Sandler, R.B., Bayles, C.M., Robertson, R.J., et al. (1987). The decline of grip strength in menopause: Relationship to physical activity, estrogen use, and anthropometric factors. Journal of Chronic Diseases, 40(2), 115-120.
Chen, Z., Maricic, M., Bassford, T.L., Pettinger, M., Ritenbaugh, C., & Lopez, A.M. (2005). Fracture risk among breast cancer survivors: Results from the Women's Health Initiative Observational Study. Archives of Internal Medicine, 165(5), 552-558.
Chen, Z., Maricic, M., Pettinger, M., Ritenbaugh, C., Lopez, A., Barad, D., et al. (2005). Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer, 104(7), 1520-1530.
Cheney, C.L., Mahloch, J., & Freeny, P. (1997). Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. American Journal of Clinical Nutrition, 66(1), 141-146.
Coleman, R.E., Banks, L.M., Girgis, S.I., Kilburn, L.S., Vrdoljak, E., & Fox, J. (2007). Skeletal effects of exemestane on bone mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): A randomized controlled study. Lancet Oncology, 8(2), 119.
Coombes, R.C., Hall, E., Gibson, L.J., Paridaens, R., Jassem, J., & Delozier, T. (2004). A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350(11), 1081-1092.
Costa, L.J., Varella, P.C., & del Giglio, A. (2002). Weight changes during chemotherapy for breast cancer. Sao Paulo Medical Journal, 120(4), 113-117.
Crandall, C., Petersen, L., Ganz, P.A., & Greendale, G.A. (2004). Bone mineral density and adjuvant therapy in breast cancer survivors. Breast Cancer Research and Treatment, 88(3), 257.
Cummings, S., & Nevitt, M. (1994). Nonskeletal determinants of fractures: The potential importance of the mechanics of falls. Osteoporosis International, 1, 67-70.
Delmas, P.D., Balena, R., Confravreux, E., Hardouin, C., Hardy, P., & Bremond, A. (1997). Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study. Journal of Clinical Oncology, 15(3), 955-962.
Demark-Wahnefried, W., Peterson, B.L., Winer, E.P., Marks, L., Aziz, N., Marcom, P.K., et al. (2001). Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 19(9), 2381-2389.
Demark-Wahnefried, W., Rimer, B.K., & Winer, E.P. (1997). Weight gain in women diagnosed with breast cancer. Journal of the American Dietetic Association, 97(5), 519-526, 529.
Demark-Wahnefried, W., Winer, E.P., & Rimer, B.K. (1993). Why women gain weight with adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 11(7), 1418-1429.
Eifel, P., Axelson, J.A., Costa, J., Crowley, J., Curran, W.J., Jr., Deshler, A., et al. (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. Journal of the National Cancer Institute, 93(13), 979-989.
Freedman, R.J., Aziz, N., Albanes, D., Hartman, T., Danforth, D., Hill, S., et al. (2004). Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. Journal of Clinical Endocrinology and Metabolism, 89(5), 2248-2253.
Frost, H.M. (2001). Should future risk-of-fracture analyses include another major risk factor? The case for falls. Journal of Clinical Densitometry, 4(4), 381-383.
Ganz, D.A., Higashi, T., & Rubenstein, L.Z. (2005). Monitoring falls in cohort studies of community-dwelling older people: Effect of the recall interval. Journal of the American Geriatric Society, 53(12), 2190-2194.
Goodwin, P.J., Ennis, M., Pritchard, K.I., McCready, D., Koo, J., Sidlofsky, S., et al. (1999). Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. Journal of Clinical Oncology, 17(8), 2365-2370.
Greep, N.C., Giuliano, A.E., Hansen, N.M., Taketani, T., Wang, H.J., & Singer, F.R. (2003). The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. American Journal of Medicine, 114(8), 653-659.
Harvie, M.N., Campbell, I.T., Baildam, A., & Howell, A. (2004). Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Research and Treatment, 83(3), 201-210.
Headley, J.A., Theriault, R.L., LeBlanc, A.D., Vassilopoulou-Sellin, R., & Hortobagyi, G.N. (1998). Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. Cancer Investigations, 16(1), 6-11.
Heaney, R.P. (2003). Is the paradigm shifting? Bone, 33(4), 457-465.
Hoskin, P.J., Ashley, S., & Yarnold, J.R. (1992). Weight gain after primary surgery for breast cancer—Effect of tamoxifen. Breast Cancer Research and Treatment, 22(2), 129-132.
Hou, M.F., Tsai, L.Y., Tsai, S.M., Huang, C.J., Huang, Y.S., Hsieh, J.S., et al. (1999). Biochemical markers for assessment of bone metastases in patients with breast cancer. Kaohsiung Journal of Medical Science, 15(8), 452-460.
Jackson, C., Gaugris, S., Sen, S.S., & Hosking, D. (2007). The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: A meta-analysis. Quarterly Journal of Medicine, 100(4), 185-192.
Kanis, J.A., McCloskey, E.V., Powles, T., Paterson, A.H., Ashley, S., & Spector, T. (1999). A high incidence of vertebral fracture in women with breast cancer. British Journal of Cancer, 79(7-8), 1179-1181.
Kohrt, W.M., Bloomfield, S.A., Little, K.D., Nelson, M.E., & Yingling, V.R. (2004). American College of Sports Medicine position: Physical activity and bone health. Medicine and Science in Sports and Exercise, 36(11), 1985-1996.
Kristensen, B., Ejlertsen, B., Dalgaard, P., Larsen, L., Holmegaard, S.N., Transbol, I., et al. (1994). Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: A randomized study. Journal of Clinical Oncology, 12(5), 992-997.
Kutynec, C.L., McCargar, L., Barr, S.I., & Hislop, T.G. (1999). Energy balance in women with breast cancer during adjuvant treatment. Journal of the American Dietetic Association, 99(10), 1222-1227.
Lamont, E.B., & Lauderdale, D.S. (2003). Low risk of hip fracture among elderly breast cancer survivors. Annals of Epidemiology, 13(10), 698-703.
Lindsey, A.M., Gross, G., Twiss, J., Waltman, N., Ott, C., & Moore, T.E. (2002). Postmenopausal survivors of breast cancer at risk for osteoporosis: Nutritional intake and body size. Cancer Nursing, 25(1), 50-56.
Love, R.R., Mazess, R.B., Barden, H.S., Epstein, S., Newcomb, P.A., & Jordan, V.C. (1992). Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. New England Journal of Medicine, 326(13), 852-856.
O'Connell, B.O., Baker, L., Gaskin, C.J., & Hawkins, M.T. (2007). Risk items associated with patient falls in oncology and medical settings. Journal of Nursing Care Quality, 22(2), 130-137.
Overcash, J. (2007). Prediction of falls in older adults with cancer: A preliminary study. Oncology Nursing Forum, 34(2), 341-346.
Pouilles, J.M., Tremollieres, F., & Ribot, C. (1995). Effect of menopause on femoral and vertebral bone loss. Journal of Bone and Mineral Research, 10(10), 1531-1536.
Richardson, J.K., & Hurvitz, E.A. (1995). Peripheral neuropathy: A true risk factor for falls. Journal of Gerontology, 50(4), M211-M215.
Riggs, B., & Melton, L.R. (2002). Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. Journal of Bone and Mineral Research, 17(1), 11-14.
Saarto, T., Blomqvist, C., Valimaki, M., Makela, P., Sarna, S., & Elomaa, I. (1997). Clodronate improves bone mineral density in postmenopausal breast cancer patients treated with adjuvant antioestrogens. British Journal of Cancer, 75(4), 602-605.
Saarto, T., Vehmanen, L., Elomaa, I., Valimaki, M., Makela, P., & Blomqvist, C. (2001). The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer. British Journal of Cancer, 84(8), 1047-1051.
Schagen, S.B., Muller, M.J., Boogerd, W., Mellenbergh, G.J., & van Dam, F.S. (2006). Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98(23), 1742-1745.
Shapiro, C.L., Manola, J., & Leboff, M. (2001). Ovarian failure after adjuvant chemotherapy associated with rapid bone loss in early-stage breast cancer. Journal of Clinical Oncology, 19(14), 3306-3311.
Suresh, M., & Naidu, D.M. (2006). Influence of years since menopause on bone mineral metabolism in South Indian women. Indian Journal of Medical Science, 60(5), 190-198.
Tinetti, M., Speechley, M., & Ginter, S. (1988). Risk factors for falls among elderly persons living in the community. New England Journal of Medicine, 319(26), 1701-1707.
Torgerson, D.J., Garton, M.J., & Reid, D.M. (1993). Falling and perimenopausal women. Age and Ageing, 22(1), 59-64.
Twiss, J.J., Gross, G.J., Waltman, N.L., Ott, C.D., & Lindsey, A.M. (2006). Health behaviors in breast cancer survivors experiencing bone loss. Journal of the American Academy of Nurse Practitioners, 18(10), 471-481.
Twiss, J.J., Waltman, N., Ott, C.D., Gross, G.J., Lindsey, A.M., & Moore, T.E. (2001). Bone mineral density in postmenopausal breast cancer survivors. Journal of the American Academy of Nurse Practitioners, 13(6), 276-284.
Vehmanen, L., Saarto, T., Elomaa, I., Makela, P., Valimaki, M., & Blomqvist, C. (2001). Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients: The effect of adjuvant clodronate treatment. European Journal of Cancer, 37(18), 2373-2378.
Wampler, M.A., Topp, K.S., Miaskowski, C., Byl, N.N., Rugo, H.S., & Hamel, K. (2007). Quantitative and clinical description of postural instability in women with breast cancer treated with taxane chemotherapy. Archives of Physical Medicine and Rehabilitation, 88(8), 1002-1008.
Winner, S.J., Morgan, C.A., & Evans, J.G. (1989). Perimenopausal risk of falling and incidence of distal forearm fracture. BMJ, 298(6686), 1486-1488.
Winters, K.M., & Snow, C.M. (2000a). Body composition predicts bone mineral density and balance in premenopausal women. Journal of Womens Health and Gender Based Medicine, 9(8), 865-872.
Winters, K.M., & Snow, C.M. (2000b). Detraining reverses positive effects of exercise on the musculoskeletal system in premenopausal women. Journal of Bone and Mineral Research, 15(12), 2495-2503.
Zhou, Z., Redaelli, A., Johnell, O., Willke, R.J., & Massimini, G. (2004). A retrospective analysis of health care costs for bone fractures in women with early-stage breast carcinoma. Cancer, 100(3), 507-517.